Related Experiment Videos
Patient selection for prostate brachytherapy: more myth than fact
Gregory S Merrick1, Kent E Wallner, Wayne M Butler
1Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, West Virginia 26003-6300, USA. SchifflerCancerCenter@wheelinghospital.com
Oncology (Williston Park, N.Y.)
|May 12, 2004
Summary
This study reviews prostate brachytherapy, highlighting that patient selection significantly impacts treatment success and side effects. Evidence-based factors, not physician bias, should guide patient selection for better outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Urology
Background:
- Prostate brachytherapy's effectiveness and side effects depend on implant quality and patient care.
- Many contraindications for brachytherapy are based on opinion rather than data.
- Evidence-based factors influencing radiation morbidity are increasingly recognized.
Purpose of the Study:
- To differentiate between evidence-based and unsubstantiated patient selection factors in prostate brachytherapy.
- To guide refinements in patient selection for improved treatment outcomes.
Main Methods:
- Review of existing clinical data and literature.
- Analysis of factors affecting prostate brachytherapy efficacy and morbidity.
- Comparison of evidence-based versus unsubstantiated patient selection criteria.
Main Results:
- Identified specific evidence-based factors that influence prostate brachytherapy outcomes.
- Distinguished between factors supported by clinical data and those based on physician bias.
- Highlighted the potential for improved biochemical and quality-of-life results through refined patient selection.
Conclusions:
- Optimizing patient selection for prostate brachytherapy is crucial for maximizing efficacy and minimizing morbidity.
- Relying on evidence-based criteria over unsubstantiated factors can enhance treatment success.
- Further refinements in patient selection promise better biochemical control and quality of life.